abstract |
The present invention relates to the use of an antifungal agent of a compound capable of binding to a mannoprotein and blocking the binding of said mannoprotein to an endothelial cell receiver in the production of a pharmaceutical composition for treating an illness associated with unwanted cell adhesion. Likewise, the present invention also relates to methods aimed at identifying a compound that can potentially be used for preventing and/or treating an illness associated with unwanted cell adhesion, for predicting the likelihood of a cancer patient suffering metastasis and for designing a personalised therapy for a cancer patient. |